Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Receptor Tyrosine Protein Kinase Targeted Drugs market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Receptor Tyrosine Protein Kinase Targeted Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Receptor Tyrosine Protein Kinase Targeted Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Zensun (Shanghai) Sci & Tech Co Ltd
Hanmi Pharmaceuticals Co Ltd
Aslan Pharmaceuticals Pte Ltd
Jiangsu Kanion Pharmaceutical Co Ltd
Shanghai Fosun Pharmaceutical (Group) Co Ltd
GamaMabs Pharma SA
XuanZhu Pharma Co Ltd
Puma Biotechnology Inc
Minerva Neurosciences Inc
Pfizer Inc
Boehringer Ingelheim GmbH
By Type:
Afatinib Dimaleate
Dacomitinib
Neratinib
Others
By End-User:
Oncology
Cardiovascular
Central Nervous System
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 USA Receptor Tyrosine Protein Kinase Targeted Drugs Market Size and Growth Rate of Afatinib Dimaleate from 2016 to 2027
-
1.3.2 USA Receptor Tyrosine Protein Kinase Targeted Drugs Market Size and Growth Rate of Dacomitinib from 2016 to 2027
-
1.3.3 USA Receptor Tyrosine Protein Kinase Targeted Drugs Market Size and Growth Rate of Neratinib from 2016 to 2027
-
1.3.4 USA Receptor Tyrosine Protein Kinase Targeted Drugs Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Receptor Tyrosine Protein Kinase Targeted Drugs Market Size and Growth Rate of Oncology from 2016 to 2027
-
1.4.2 USA Receptor Tyrosine Protein Kinase Targeted Drugs Market Size and Growth Rate of Cardiovascular from 2016 to 2027
-
1.4.3 USA Receptor Tyrosine Protein Kinase Targeted Drugs Market Size and Growth Rate of Central Nervous System from 2016 to 2027
-
1.4.4 USA Receptor Tyrosine Protein Kinase Targeted Drugs Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Receptor Tyrosine Protein Kinase Targeted Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Receptor Tyrosine Protein Kinase Targeted Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of Afatinib Dimaleate
-
3.4.2 Market Size and Growth Rate of Dacomitinib
-
3.4.3 Market Size and Growth Rate of Neratinib
-
3.4.4 Market Size and Growth Rate of Others
4 Segmentation of Receptor Tyrosine Protein Kinase Targeted Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Receptor Tyrosine Protein Kinase Targeted Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Receptor Tyrosine Protein Kinase Targeted Drugs in Oncology
-
4.4.2 Market Size and Growth Rate of Receptor Tyrosine Protein Kinase Targeted Drugs in Cardiovascular
-
4.4.3 Market Size and Growth Rate of Receptor Tyrosine Protein Kinase Targeted Drugs in Central Nervous System
-
4.4.4 Market Size and Growth Rate of Receptor Tyrosine Protein Kinase Targeted Drugs in Others
5 Market Analysis by Regions
-
5.1 USA Receptor Tyrosine Protein Kinase Targeted Drugs Production Analysis by Regions
-
5.2 USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Receptor Tyrosine Protein Kinase Targeted Drugs Landscape Analysis
-
6.1 West USA Receptor Tyrosine Protein Kinase Targeted Drugs Landscape Analysis by Major Types
-
6.2 West USA Receptor Tyrosine Protein Kinase Targeted Drugs Landscape Analysis by Major End-Users
7 South USA Receptor Tyrosine Protein Kinase Targeted Drugs Landscape Analysis
-
7.1 South USA Receptor Tyrosine Protein Kinase Targeted Drugs Landscape Analysis by Major Types
-
7.2 South USA Receptor Tyrosine Protein Kinase Targeted Drugs Landscape Analysis by Major End-Users
8 Middle West USA Receptor Tyrosine Protein Kinase Targeted Drugs Landscape Analysis
-
8.1 Middle West USA Receptor Tyrosine Protein Kinase Targeted Drugs Landscape Analysis by Major Types
-
8.2 Middle West USA Receptor Tyrosine Protein Kinase Targeted Drugs Landscape Analysis by Major End-Users
9 Northeast USA Receptor Tyrosine Protein Kinase Targeted Drugs Landscape Analysis
-
9.1 Northeast USA Receptor Tyrosine Protein Kinase Targeted Drugs Landscape Analysis by Major Types
-
9.2 Northeast USA Receptor Tyrosine Protein Kinase Targeted Drugs Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Zensun (Shanghai) Sci & Tech Co Ltd
-
10.1.1 Zensun (Shanghai) Sci & Tech Co Ltd Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Hanmi Pharmaceuticals Co Ltd
-
10.2.1 Hanmi Pharmaceuticals Co Ltd Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Aslan Pharmaceuticals Pte Ltd
-
10.3.1 Aslan Pharmaceuticals Pte Ltd Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Jiangsu Kanion Pharmaceutical Co Ltd
-
10.4.1 Jiangsu Kanion Pharmaceutical Co Ltd Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Shanghai Fosun Pharmaceutical (Group) Co Ltd
-
10.5.1 Shanghai Fosun Pharmaceutical (Group) Co Ltd Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 GamaMabs Pharma SA
-
10.6.1 GamaMabs Pharma SA Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 XuanZhu Pharma Co Ltd
-
10.7.1 XuanZhu Pharma Co Ltd Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Puma Biotechnology Inc
-
10.8.1 Puma Biotechnology Inc Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Minerva Neurosciences Inc
-
10.9.1 Minerva Neurosciences Inc Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Pfizer Inc
-
10.10.1 Pfizer Inc Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Boehringer Ingelheim GmbH
-
10.11.1 Boehringer Ingelheim GmbH Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Receptor Tyrosine Protein Kinase Targeted Drugs Market Size and Growth Rate of Afatinib Dimaleate from 2016 to 2027
-
Figure USA Receptor Tyrosine Protein Kinase Targeted Drugs Market Size and Growth Rate of Dacomitinib from 2016 to 2027
-
Figure USA Receptor Tyrosine Protein Kinase Targeted Drugs Market Size and Growth Rate of Neratinib from 2016 to 2027
-
Figure USA Receptor Tyrosine Protein Kinase Targeted Drugs Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Receptor Tyrosine Protein Kinase Targeted Drugs Market Size and Growth Rate of Oncology from 2016 to 2027
-
Figure USA Receptor Tyrosine Protein Kinase Targeted Drugs Market Size and Growth Rate of Cardiovascular from 2016 to 2027
-
Figure USA Receptor Tyrosine Protein Kinase Targeted Drugs Market Size and Growth Rate of Central Nervous System from 2016 to 2027
-
Figure USA Receptor Tyrosine Protein Kinase Targeted Drugs Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Receptor Tyrosine Protein Kinase Targeted Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Receptor Tyrosine Protein Kinase Targeted Drugs
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Receptor Tyrosine Protein Kinase Targeted Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Receptor Tyrosine Protein Kinase Targeted Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Afatinib Dimaleate
-
Figure Market Size and Growth Rate of Dacomitinib
-
Figure Market Size and Growth Rate of Neratinib
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Receptor Tyrosine Protein Kinase Targeted Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Receptor Tyrosine Protein Kinase Targeted Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Oncology
-
Figure Market Size and Growth Rate of Cardiovascular
-
Figure Market Size and Growth Rate of Central Nervous System
-
Figure Market Size and Growth Rate of Others
-
Table USA Receptor Tyrosine Protein Kinase Targeted Drugs Production by Regions
-
Table USA Receptor Tyrosine Protein Kinase Targeted Drugs Production Share by Regions
-
Figure USA Receptor Tyrosine Protein Kinase Targeted Drugs Production Share by Regions in 2016
-
Figure USA Receptor Tyrosine Protein Kinase Targeted Drugs Production Share by Regions in 2021
-
Figure USA Receptor Tyrosine Protein Kinase Targeted Drugs Production Share by Regions in 2027
-
Table USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption by Regions
-
Table USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by Regions
-
Figure USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by Regions in 2016
-
Figure USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by Regions in 2021
-
Figure USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by Regions in 2027
-
Table West USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption by Types from 2016 to 2027
-
Table West USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by Types from 2016 to 2027
-
Figure West USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by Types in 2016
-
Figure West USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by Types in 2021
-
Figure West USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by Types in 2027
-
Table West USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption by End-Users from 2016 to 2027
-
Table West USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by End-Users in 2016
-
Figure West USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by End-Users in 2021
-
Figure West USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by End-Users in 2027
-
Table South USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption by Types from 2016 to 2027
-
Table South USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by Types from 2016 to 2027
-
Figure South USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by Types in 2016
-
Figure South USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by Types in 2021
-
Figure South USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by Types in 2027
-
Table South USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption by End-Users from 2016 to 2027
-
Table South USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by End-Users in 2016
-
Figure South USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by End-Users in 2021
-
Figure South USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by End-Users in 2027
-
Table Middle West USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption by Types from 2016 to 2027
-
Table Middle West USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by Types in 2016
-
Figure Middle West USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by Types in 2021
-
Figure Middle West USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by Types in 2027
-
Table Middle West USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by End-Users in 2016
-
Figure Middle West USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by End-Users in 2021
-
Figure Middle West USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by End-Users in 2027
-
Table Northeast USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption by Types from 2016 to 2027
-
Table Northeast USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by Types in 2016
-
Figure Northeast USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by Types in 2021
-
Figure Northeast USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by Types in 2027
-
Table Northeast USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by End-Users in 2016
-
Figure Northeast USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by End-Users in 2021
-
Figure Northeast USA Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Zensun (Shanghai) Sci & Tech Co Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zensun (Shanghai) Sci & Tech Co Ltd
-
Figure Sales and Growth Rate Analysis of Zensun (Shanghai) Sci & Tech Co Ltd
-
Figure Revenue and Market Share Analysis of Zensun (Shanghai) Sci & Tech Co Ltd
-
Table Product and Service Introduction of Zensun (Shanghai) Sci & Tech Co Ltd
-
Table Company Profile and Development Status of Hanmi Pharmaceuticals Co Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hanmi Pharmaceuticals Co Ltd
-
Figure Sales and Growth Rate Analysis of Hanmi Pharmaceuticals Co Ltd
-
Figure Revenue and Market Share Analysis of Hanmi Pharmaceuticals Co Ltd
-
Table Product and Service Introduction of Hanmi Pharmaceuticals Co Ltd
-
Table Company Profile and Development Status of Aslan Pharmaceuticals Pte Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aslan Pharmaceuticals Pte Ltd
-
Figure Sales and Growth Rate Analysis of Aslan Pharmaceuticals Pte Ltd
-
Figure Revenue and Market Share Analysis of Aslan Pharmaceuticals Pte Ltd
-
Table Product and Service Introduction of Aslan Pharmaceuticals Pte Ltd
-
Table Company Profile and Development Status of Jiangsu Kanion Pharmaceutical Co Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jiangsu Kanion Pharmaceutical Co Ltd
-
Figure Sales and Growth Rate Analysis of Jiangsu Kanion Pharmaceutical Co Ltd
-
Figure Revenue and Market Share Analysis of Jiangsu Kanion Pharmaceutical Co Ltd
-
Table Product and Service Introduction of Jiangsu Kanion Pharmaceutical Co Ltd
-
Table Company Profile and Development Status of Shanghai Fosun Pharmaceutical (Group) Co Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai Fosun Pharmaceutical (Group) Co Ltd
-
Figure Sales and Growth Rate Analysis of Shanghai Fosun Pharmaceutical (Group) Co Ltd
-
Figure Revenue and Market Share Analysis of Shanghai Fosun Pharmaceutical (Group) Co Ltd
-
Table Product and Service Introduction of Shanghai Fosun Pharmaceutical (Group) Co Ltd
-
Table Company Profile and Development Status of GamaMabs Pharma SA
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GamaMabs Pharma SA
-
Figure Sales and Growth Rate Analysis of GamaMabs Pharma SA
-
Figure Revenue and Market Share Analysis of GamaMabs Pharma SA
-
Table Product and Service Introduction of GamaMabs Pharma SA
-
Table Company Profile and Development Status of XuanZhu Pharma Co Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of XuanZhu Pharma Co Ltd
-
Figure Sales and Growth Rate Analysis of XuanZhu Pharma Co Ltd
-
Figure Revenue and Market Share Analysis of XuanZhu Pharma Co Ltd
-
Table Product and Service Introduction of XuanZhu Pharma Co Ltd
-
Table Company Profile and Development Status of Puma Biotechnology Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Puma Biotechnology Inc
-
Figure Sales and Growth Rate Analysis of Puma Biotechnology Inc
-
Figure Revenue and Market Share Analysis of Puma Biotechnology Inc
-
Table Product and Service Introduction of Puma Biotechnology Inc
-
Table Company Profile and Development Status of Minerva Neurosciences Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Minerva Neurosciences Inc
-
Figure Sales and Growth Rate Analysis of Minerva Neurosciences Inc
-
Figure Revenue and Market Share Analysis of Minerva Neurosciences Inc
-
Table Product and Service Introduction of Minerva Neurosciences Inc
-
Table Company Profile and Development Status of Pfizer Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc
-
Figure Sales and Growth Rate Analysis of Pfizer Inc
-
Figure Revenue and Market Share Analysis of Pfizer Inc
-
Table Product and Service Introduction of Pfizer Inc
-
Table Company Profile and Development Status of Boehringer Ingelheim GmbH
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim GmbH
-
Figure Sales and Growth Rate Analysis of Boehringer Ingelheim GmbH
-
Figure Revenue and Market Share Analysis of Boehringer Ingelheim GmbH
-
Table Product and Service Introduction of Boehringer Ingelheim GmbH
-
